GB201510493D0 - Compounds - Google Patents
CompoundsInfo
- Publication number
- GB201510493D0 GB201510493D0 GBGB1510493.8A GB201510493A GB201510493D0 GB 201510493 D0 GB201510493 D0 GB 201510493D0 GB 201510493 A GB201510493 A GB 201510493A GB 201510493 D0 GB201510493 D0 GB 201510493D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4965—Non-condensed pyrazines
- A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB1510493.8A GB2548542A (en) | 2015-06-16 | 2015-06-16 | Compounds |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB1510493.8A GB2548542A (en) | 2015-06-16 | 2015-06-16 | Compounds |
Publications (2)
Publication Number | Publication Date |
---|---|
GB201510493D0 true GB201510493D0 (en) | 2015-07-29 |
GB2548542A GB2548542A (en) | 2017-09-27 |
Family
ID=53784763
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB1510493.8A Withdrawn GB2548542A (en) | 2015-06-16 | 2015-06-16 | Compounds |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB2548542A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114573510A (en) * | 2015-12-16 | 2022-06-03 | 洛克索肿瘤学股份有限公司 | Compounds useful as kinase inhibitors |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108424414A (en) * | 2017-12-08 | 2018-08-21 | 苏州国匡医药科技有限公司 | Indoleamine 2,3-dioxygenase modulating compound of the one kind containing heterocycle and its purposes in pharmacy |
CN108467365B (en) * | 2018-03-12 | 2021-05-04 | 郑州工程技术学院 | IDO enzyme inhibitor compound and preparation method and application thereof |
US11351149B2 (en) | 2020-09-03 | 2022-06-07 | Pfizer Inc. | Nitrile-containing antiviral compounds |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NO2694640T3 (en) * | 2011-04-15 | 2018-03-17 | ||
RU2667509C2 (en) * | 2013-03-14 | 2018-09-21 | Ньюлинк Джинетикс Корпорейшин | Tricyclic compounds as inhibitors of immunosuppression mediated by tryptophan metabolization |
CN105037371A (en) * | 2015-06-30 | 2015-11-11 | 西华大学 | Deuterated indoleamine-2,3-dioxygenase inhibitor |
-
2015
- 2015-06-16 GB GB1510493.8A patent/GB2548542A/en not_active Withdrawn
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114573510A (en) * | 2015-12-16 | 2022-06-03 | 洛克索肿瘤学股份有限公司 | Compounds useful as kinase inhibitors |
CN114591242A (en) * | 2015-12-16 | 2022-06-07 | 洛克索肿瘤学股份有限公司 | Compounds useful as kinase inhibitors |
CN114634447A (en) * | 2015-12-16 | 2022-06-17 | 洛克索肿瘤学股份有限公司 | Compounds useful as kinase inhibitors |
Also Published As
Publication number | Publication date |
---|---|
GB2548542A (en) | 2017-09-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB201510019D0 (en) | Compounds | |
GB201514754D0 (en) | Compounds | |
GB201514751D0 (en) | Compounds | |
PL3362444T3 (en) | Compounds | |
GB201508747D0 (en) | Compounds | |
GB201520500D0 (en) | Compounds | |
GB201520499D0 (en) | Compounds | |
GB201508864D0 (en) | Compounds | |
IL253813A0 (en) | Diaza-benzofluoranthrene compounds | |
GB201510493D0 (en) | Compounds | |
PT3331885T (en) | Compounds | |
GB201521682D0 (en) | Compounds | |
GB201520419D0 (en) | Compounds | |
GB201508857D0 (en) | Compounds | |
GB201503926D0 (en) | Compounds | |
GB201501115D0 (en) | Compounds | |
GB201522246D0 (en) | Compounds | |
GB201521912D0 (en) | Compounds | |
GB201521440D0 (en) | Compounds | |
GB201521086D0 (en) | Compounds | |
GB201519969D0 (en) | Compounds | |
GB201519965D0 (en) | Compounds | |
GB201519549D0 (en) | Compounds | |
GB201519213D0 (en) | Compounds | |
GB201519212D0 (en) | Compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WAP | Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1) |